Background-Little is known about the importation of a heart failure disease management program (HFDMP) into lowand middle-income countries. We examined the feasibility of importing a HFDMP into the country of Georgia, located in the Caucuses. Methods and Results-Patients with ejection fraction Յ40% were enrolled into a prospective, observational study consisting of a new HFDMP staffed by local cardiologists. Medications, emergency department use, hospital admissions, and mortality were assessed by interviews with patients or their families. Screening resulted in 400 patients who were followed for 10.2Ϯ3.5 months. ␤-Blocker prescriptions increased from 7.4 -80.7% (PϽ0.001), angiotensinconverting enzyme inhibitor prescriptions increased from 18.4 -92.6% (PϽ0.001), and mean systolic blood pressure declined from 145 to 114 mm Hg (PϽ0.001). Patients visiting the emergency department and hospitalizations were lowered by 40.7% and 52.5%, respectively, but were also influenced by the outbreak of war, during which 17.5% (nϭ70) of patients received follow-up in refugee tents. All-cause mortality extended to 7% of patients, with 12 of 28 deaths caused by war-related events. Conclusions-Importation of a Western HFDMP was demonstrated to be feasible, with a 5-fold increase in the use of recommended therapies, reduction of blood pressure, decrease of emergency department visits, and hospitalizations for heart failure. These measures could result in substantial cost savings in resource-limited settings, but assessment is complicated in unstable areas. Translating effective interventions to low-and middle-income countries requires sensitivity to regional cultures and flexibility to adapt both clinical goals and strategies to unexpected conditions. (Circ Heart Fail. 2011;4:763-769.)
T he country of Georgia, located in the Caucuses, is unique in having recently experienced major changes in its health care delivery system from the inherited Soviet Union model of universal low-cost health care to a largely fee-forservice system. A cross-sectional survey conducted in 2001 revealed that 70% of Georgians failed to seek medical care mainly because of unaffordability. 1 In addition, this transition of the health care system resulted in large unemployment rate for physicians. According to the World Health Organization Surveillance of Chronic Risk Factor Report, 2 adults from the country of Georgia have the second highest mean blood pressure in the world. Such high levels of uncontrolled hypertension are a public health concern for a variety of reasons including the potential to develop heart failure (HF).
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In the United States, HF is frequently treated through disease management programs (DMPs), which are based on the principles of coordinated care, evidence-based treatment, and outcomes evaluation. 3 HFDMPs have generally been found to improve patient outcomes by reducing health care cost, emergency department (ED) utilization, hospital admissions, and mortality while improving quality of life. 4 -14 A recent meta-analysis showed that HFDMPs reduced the risk of mortality by 20% compared with usual care. 4 In addition, Young found that patients enrolled in a DMP required significantly fewer ED visits and reduced number of diagnostic and therapeutic services than usual care patients. 5 With respect to international studies, a meta-analysis of 36 HFDMP studies from 13 different countries documented reduction in mortality and hospitalizations by 3% and 8%, respectively. 15 Given the critical role of pharmacological interventions for the treatment of systolic HF in the low-and middle-income countries (LMIC), this study sought to implement a pilot HFDMP in the country of Georgia, focusing on therapies that are evidence-based and cost-effective. The general process of translating a DMP to a LMIC involves several steps, including gaining stakeholder support, adjusting the delivery of care according to the evidenced-based guidelines, and reallocating financial and human resources to facilitate implementation of these services. In addition, effective clinical information systems including patient registries are an essential tool for providing the necessary continuity of care for chronic diseases. 16 -20 We examined the feasibility of importing a HFDMP into this population through specific teaching of cardiologists, screening for ejection fraction (EF) Յ40%, and monitoring of the prescribed medications during the 16 months of the program. Additionally, we evaluated clinical outcomes including ED utilization, hospital admissions, and mortality.
Methods

Design and Setting
A prospective, observational cohort study was conducted by recruiting patients into a new pilot HFDMP at Central University Hospital, a tertiary academic facility in Tbilisi, Georgia.
Patient Recruitment
To include adult participants from both urban and rural areas, but also anticipating patient abandonment due to lack of transportation, patients were recruited from 1 urban hospital and 3 rural districts, based on the geographical proximity to the hospital, particularly within a radius of 200 km. The availability of the new HFDMP was broadcast on several nightly television programs. Likewise, government health administrators for these 3 districts were contacted with screening programs for patients with known cardiovascular disease, hypertension, or new symptoms suggestive of HF. Screening echocardiograms were performed by cardiologists at the 3 rural sites. Patients were eligible to participate if they were Ն18 years of age and had EF Յ40% by echocardiography with or without symptoms of HF (Figure) . Enrollment commenced in August 2007 and was completed by July 2008 with all the eligible candidates. Each patient signed a consent form explained by a native Georgian. The Central University Hospital in Tbilisi, Georgia, and the University of Miami, Miller School of Medicine, Institutional Review Board, approved this study.
Intervention: HFDMP
One cardiologist from United States experienced in implementing successful HFDMPs in resource-limited settings and 1 internal medicine resident from the University of Miami established the components for the processes of care, including development of tools for patient education. Two Georgian cardiologists were trained over a period of 3 weeks to screen, enroll, and treat patients in an HFDMP. This training included lectures from the guidelines for heart failure of the American College of Cardiology (ACC) and the American Heart Association (AHA), 21 standardization and demonstration of a cardiovascular examination, instructions on medication titration, and review of data collection tools. The equipment provided included a portable 2D echo, scale, stethoscope, blood pressure (BP) sphygmomanometer, hand-held pulse Doppler, laptop computer, copy machine, and salary support for 2 part-time Georgian cardiologists for a period of 2 years.
For BP readings, the patient was seated comfortably with legs uncrossed and clothing removed from the area where the BP cuff would be placed. The back and the arm were supported and held at the midpoint of the sternum to ensure the middle of the cuff (on the upper arm) at the level of the right atrium. The bladder of the cuff encircled at least 80% of the arm circumference, and the patient was asked to refrain from speaking during the measurement.
Program Description
The program was adjusted to the taxonomy of the AHA, including its 8 domains as follows: 3 (1) Patient population: Georgian patients with an EF Յ40% by echocardiography with or without symptoms.
(2) Intervention recipient: Patients and physicians. Georgian cardiologists received lectures on the ACC/AHA guidelines for HF therapy and were supervised for 1 week during the enrollment of patients into the program. 21 The Georgian physicians were fluent in written and spoken English. A printed protocol including titration of medication was developed and adapted to Georgian resources by both the American and Georgian physicians.
(3) Intervention content: Patients were provided outpatient physician visits, screening, and follow-up 2D echoes free of charge for a period of 2 years. Patients also received written material and verbal teaching in the Georgian language covering the HF disease process, signs and symptoms of HF, medication usage, purpose, titration, and side effects. Medications, especially ␤-blockers (BB), were titrated at 2-week intervals to the maximum dose tolerated by symptoms and thereafter followed every 3 months. In addition, patients received instructions on recording daily medications and weight as well as sliding scale of diuretic dosage for weight gains of greater than 2 pounds. Patients were also taught the AHA 5 stroke signs 22 and were counseled and received written instructions to stop or refrain from smoking. Patients were given the phone number of their cardiologists and were encouraged to call with any questions. Medications were not provided for free, but prescriptions were dispensed to the patients.
(4) Delivery personnel: Two full-time Georgian cardiologists. Nursing personnel were not included in this study because of budget restrictions.
(5) Method of communication: Clinic visits and phone contact. (6) Intensity and complexity: After the initial 8-week period in which medications were titrated to maximum doses tolerated by symptoms (such as light-headedness, weakness, or fatigue), patients attended to routine clinic visits every 3 months. However, the protocol was modified because the war occurred, and some patients were displaced into refugee camps. For these patients, physician visits took place in the camps, using a battery-run portable echocardiography machine. Data were also collected on demographics, BP, EF, New York Heart Association (NYHA) class, body mass index, insurance status, income level, money spent on medications per month, comorbidities, smoking, and education level. On follow-up visits, in addition to volume status on physical examination, BP, pulse, weight, medications, smoking cessation, and NYHA class were assessed. EF was measured using portable echocardiography at baseline and at the end of the program. The studies were performed and read by the 2 Georgian cardiologists. EF was obtained by the average of 3 measurements assessed by visual estimation. Loss to follow-up was considered when the patient, for various reasons, did not complete a second clinical visit. Patients who were lost to follow-up and family members of those patients who died were contacted by telephone and interviewed for clinical assessment inquiries as well as to elucidate the cause of death.
Statistical Analyses
Categorical variables are expressed as total number of patients and percentages. Continuous variables are presented as meanϮSD. Group differences in clinical characteristics were evaluated by calculating the change, increase or decrease, from baseline to postenrollment. Analysis was considered in the patient population who completed the program. Patients who were lost to follow-up were removed from the final analysis. Deaths were attributed to cardiac causes if any documentation of arrhythmia, cardiac arrest, or myocardial infarction was available. Differences in categorical values are expressed as a percent change from baseline to postenrollment and evaluated by Wilcoxon matched-pairs, signed rank test. Differences in continuous variables are expressed as the average unit change from baseline to postenrollment per each patient and evaluated by paired t test. Univariate analysis was performed to address whether demographic and clinic characteristics of the patient population influenced the outcomes of the program. Multivariate models by estimating generalized equations and Cox proportional hazards were constructed to analyze the resource utilization and mortality. A value of PϽ0.05 was considered statistically significant. All analysis was performed using SPSS v 18.0, Chicago IL.
Results
Two thousand five hundred adults were screened from 4 geographical areas. Of those, 2100 did not meet inclusion criteria of having EF Յ40%. The eligible 400 patients were then enrolled into the program (Figure) . Three hundred thirty-seven enrolled patients had complete information from the baseline to the end of the program. The follow-up period ranged from 5.1 to 16.4 months after enrollment into the HFDMP, with the mean follow-up time of 10.2Ϯ3.5 months. Demographics of the population are shown in Table 1 . Except for the geographical location of patients at baseline, there were no major differences at baseline. Clinical parameters at baseline and the end of the follow-up are presented in Table  2 , demonstrating the low initial prescription of BB (7.4%) and angiotensin-converting enzyme inhibitors (ACEI, 18.4%). Patient-reported usage of these recommended medications revealed an increase of Ͼ5-fold in ACEI and 10-fold in BB, respectively (PϽ0.001 for both comparisons, Table 2 ).
The average number of medications reported by patients at completion of the program was 2.7Ϯ1.3 medications per individual. The most common dosages of ACEI were daily enalapril, 40 mg (75%), 20 mg (13%), or 10 mg (8%). Carvedilol was used as 25 mg twice a day (67%) or 12.5 mg twice a day (4.3%). The most common dosages of metoprolol were 200 mg (10%) or 100 mg (5%) daily. Furosemide dosages were 40 mg (51%), 80 mg daily (27%), or 120 mg daily (13%). Additionally, aspirin intake of 100 mg daily was reported by 89% of patients. Importantly, reduced prevalence of smoking, improvements in systolic BP (SBP) control, and increase in EF were appreciated (Table 2) . Furthermore, the improvement in the EF continued to demonstrate the same trend despite the inclusion of the patients who died (EF ranged from 31.9Ϯ6.7% at baseline to 36.0Ϯ8.3% at followup, PϽ0.001 by paired t test).
We next evaluated whether the demographic characteristics of the population influenced the clinical outcomes. Univariate analysis disclosed that men were more likely to continue smoking during the program (odds ratio [OR], 8.2; 95% confidence interval [CI], 3.2-20.9; PϽ0.001). Further, when adjusted by the geographical location of the patients as a confounder variable, there were differences at baseline in the age and initial SBP measured (PϽ0.05 for both comparisons), but this did not influence the overall outcomes at the end of the program (online-only Data Supplement Table I ). Other characteristics did not have further impact in the observed clinical response. The success of training 2 Georgian cardiologists was measured by chart review demonstrating protocol compliance, but there was no formal individual posttraining written evaluation.
Resource Utilization
Patients who visited the ED and hospital admissions for HF were examined by patient report for the year previous to enrollment (baseline) and compared with the 10.2Ϯ3.5 months of the follow-up period. The patients with regular attendance and those lost to follow-up (nϭ51, 13%) were recontacted at the end of the program to obtain information on current medication usage, ED visits, and hospital admissions since enrollment in the HFDMP. The most prevalent reasons that patients reported dropping out of the program were lack of transportation (33%) or dislike of the clinic (27%), whereas others reported preference to obtain treatment from a private doctor (21%) or were displaced by the war (17.5%). No reason was provided for the remaining 1.5% of the patients. The rate of patients who visited the ED and hospital admissions before the initiation of the intervention program accounted for 54.8% and 62.0%, respectively (Table 3) . For the subgroup of the patients who fully completed the followup, the rate of ED visits and hospital admissions were similar to the overall group (54.9% and 62.0%, respectively). Differences in ED visits and hospital admissions before and after HFDMP enrollment are also presented in Table 3 . At followup, there was a 40.7% decrease in the patients who visited the ED compared with the year before enrollment. Furthermore, hospital admissions decreased by 52.5% from the year before enrollment. Interestingly, subgroup analysis showed that BB prescription appears to be associated with a decrease in the number of patients who visited the ED (OR, 0.43; 95% CI, 0.22-0.85; Pϭ0.01; online-only Data Supplement Table II) and reduced hospital admissions (OR, 0.2; 95% CI, 0.09 -0.44; PϽ0.001; online-only Data Supplement Table III) , although a limited conclusion can be extrapolated from this data in that regard. Conversely, when the multivariate model was constructed, the effects of BB and ACEI on ED visits and hospital admissions were equivocal, but the smoking cessation program did have an impact on decreasing the number of hospital admissions (HR, 0.72; 95% CI, 0.59 -0.88; Pϭ0.001). Seventy patients (17.5%) received follow-up in refugee camps. However, it is not known to what degree the use of medical services was curtailed by the onset of war in the region.
Mortality
Twenty-eight patients died after enrollment into the HFDMP. Total mortality during the follow-up period was 7.0%. Fourteen patients who completed follow-up (4.1%) died of cardiac-related events (ie, sudden death, myocardial infarction, and/or progressive HF). Two patients died of unknown causes, and 12 patients died as a consequence of war-related events. Three hundred twenty-one patients completed the follow-up alive. Multivariate analysis over the longitudinal data did show the protective effect of BB (HR, 0.2; 95% CI, 0.043-0.88; Pϭ0.034) and EF (HR, 0.9; 95% CI, 0.83-0.98; Pϭ0.016) in cardiovascular mortality (Table 4) . Likewise, a trend for improvement in survival was found for ACEI (HR, 0.16; 95% CI, 0.02-1.04; Pϭ0.05). Subsequently, we constructed a survival analysis by Cox proportional hazards statistics in which we clustered the baseline data and the data in the follow-up period. The model showed that in addition to the above-described characteristics, the baseline smoker had an additional poor prognosis for mortality (HR, 1.64; 95% CI, 1.2-2.24; Pϭ0.002) whereas the better baseline NYHA class had a protective factor for the risk of mortality (HR, 0.58; 95% CI, 0.44 -0.76; PϽ0.001).
Discussion
This report highlights the process of implementing a previously successful HFDMP model from the United States into an LMIC. In addition, the unexpected occurrence of the war affected not only the lives of enrolled patients but also the assessment of the intervention. Adaptation of the protocol regarding follow-up was essential because of the displacement of participants into refugee camps secondary to the military conflict. Traditionally, outcomes of studies include morbidity, mortality, or resource utilization confined to the disease process itself. In countries that are not at peace, HF mortality, ED use, and hospital admission rates may not be the most important end points of our therapies. Despite the violence, we were able to demonstrate improved understanding and utilization of the recommended evidence-based therapies. This demonstrated the commitment of the Georgian people, both patients and health care providers, to improving their future health. Unanticipated collateral benefit of the program was the improvement in BP control and smoking cessation. Positive outcomes using DMP in LMIC similar to Georgia have proven to be successful such as controlling hypertension in Russia, improving glucose control in diabetes in Mexico, and reducing asthmatic exacerbation in South Africa. 16 Tbilisi, like these sites, has limited resources and significant poverty, and physicians lacked exposure to current evidence-based guidelines.
This HFDMP achieved increased medication usage in the cohort, fulfilling one of the principle aims of chronic DMPs. This accomplishment can be further linked with improvement in downstream outcomes. 23 In the present study, patients were more likely to remain on appropriate medications including BB, ACEI, and diuretics. The most pronounced impact was a 73% increase in evidence-based BB and ACEI use. Because of the improvement in medication use, we anticipated an improvement in EF, NYHA class, and BP control, which could translate to reduced ED use and hospital admissions.
Although most previous systematic reviews agree on the favorable effect of DMPs on reduced resource utilization including hospitalization, evaluation of DMPs for reduced mortality have not yielded consistent results. 15, [17] [18] [19] [20] Evaluations of DMPs for HF are difficult because, despite efforts by the AHA to promote a standardized taxonomy, a great deal of heterogeneity still exists. For example, they differed in follow-up duration, age of patients, severity of the disease, drug therapy, and intervention model. 15 Evaluation of mortality tends to be more difficult because it requires longer-term follow-up of participants before effects can be adequately evaluated. Unfortunately, HFDMP studies with 16-month follow-up or greater are limited in the medical literature. 24 For this study, patients on average were followed up to 10 months. A reduction in the number of patients who visited the ED and hospitalizations may be important because it is associated with reduced mortality and improved clinical status. 25, 26 However, the magnitude of change could not clearly be attributed to the HFDMP because of the complicating regional events that transpired after program initiation.
This study illustrates the challenges that both patients and researchers face when implementing a program or a clinical trial in a developing country with uncertain stability. Unlike in the United States, where patients with HF have this disease as their highest risk for affecting survival, such is not necessarily the case in LMIC. HF patients in Georgia are faced with war, abject poverty, malnutrition, difficulties with the transportation to health care facilities, and lack of funds for health care or medications, which can all affect their survival. At the end of the study, we noticed that an important segment of the population that was lost to follow-up was rurally located, meaning that patient distance to the clinic matters in the desertion rate. Some of these same issues affect the ability to conduct studies as they are usually performed in the Western world, with serial clinical and laboratory evaluations in stable, qualified centers. For instance, the hospital did not have a pharmacy, laboratory, or medical record department. As such, the addition of medications such as spironolactone, which requires potassium monitoring, were not used. Unlike the United States health care model, patients could purchase medications at a pharmacy without a physician prescription, creating another challenge to conducting clinical trials. Other obstacles included lack of trained nursing personnel and allied health personnel to participate in disease management in any capacity.
Working in a developing country requires a unique skill set, including culture sensitivity. Not only were patients restricted by the environment, but so too were the physicians. For instance, physicians were not aware of the ACC guidelines for HF. Also, clinic hours were based around the physicians' access to public transportation to and from the clinic. In addition, physicians had no experience in titrating medications to maximum doses tolerated based on symptoms and required the development of confidence in the American physician by the Georgian physicians, that is, the development of trust.
Though many unexpected challenges occurred, the biggest barrier for conducting research in an LMIC is the lack of grant funding to address issues regarding noncommunicable diseases in the developing world. Thus, the sustainability of this particular program is difficult to determine. The impressive results were communicated to the Minister of Health and the chief executive officers of the new insurance companies that are starting to offer insurance packages in Georgia. More than 40 cardiologists have been taught the ACC evidencebased guidelines for the management of HF after the conclusion of this program, and they are aware on how to access updated information by using the Internet.
During the communism era, the health care model offered free medical checkups and diagnostic tests, but patients had to pay for their medications. With the current report, we aimed to show that this model is feasible and had impact in the resource utilization (ie, ED visits, hospital admissions). The current situation of the health care system in Georgia is challenging as the government transitions from communism to democracy, and health care suffers from budget constraints. For the present time, patient out-of-pocket expenses for health care are high, and the deficiency in insurance programs is noted across the country. This experience could be replicated in other LMIC where the political situation is unstable, public transportation offered is limited, and health care systems have not yet been implemented.
Limitations
It is impossible to quantify the ways in which the war influenced the population or their health habits such as medication compliance, dietary adherence, and smoking. The impact of the war did affect patient retention by impairing transportation for the 33% of the cohort who were lost to follow-up and displacing 17.5% into refugee camps. Baseline and follow-up data for ED and hospital admissions may also be subject to patient recall bias. Historic mortality data before this study is not available for comparisons because there is no reliable office of vital statistics. Regarding cause of death, autopsies were not performed.
Conclusions
We have demonstrated that a sufficiently motivated patient population will attend scheduled office visits for both monitoring and treating their chronic HF condition. A low-cost HFDMP composed of patient education regarding the disease, diet, activity, and evidence-based medical therapy is both feasible and can be successfully implemented in a LMIC. Importation of an HFDMP was associated with a reduced number of patients who visited the ED and hospitalizations, which can result in substantial cost savings in resource-limited settings. This pilot program provides proof of concept that a low-cost, low-resource-intense outpatient HFDMP can address the epidemic of chronic HF in LMIC and has important health policy implications for Ministers of Health, the World Health Organization, and nongovernmental organizational funding agencies in LMIC.
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